iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Purchased by Mirae Asset Global Investments Co. Ltd.

Posted by Defense World Staff on Aug 8th, 2023

Mirae Asset Global Investments Co. Ltd. lifted its position in iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 30.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 79,455 shares of the company’s stock after acquiring an additional 18,445 shares during the period. Mirae Asset Global Investments Co. Ltd. owned 0.26% of iRhythm Technologies worth $9,855,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in IRTC. Van ECK Associates Corp increased its position in shares of iRhythm Technologies by 39.5% in the 4th quarter. Van ECK Associates Corp now owns 544 shares of the company’s stock valued at $51,000 after acquiring an additional 154 shares during the period. Carmel Capital Partners LLC acquired a new position in shares of iRhythm Technologies in the 1st quarter valued at $57,000. Parallel Advisors LLC increased its position in shares of iRhythm Technologies by 29.3% in the 4th quarter. Parallel Advisors LLC now owns 736 shares of the company’s stock valued at $69,000 after acquiring an additional 167 shares during the period. Point72 Hong Kong Ltd acquired a new position in shares of iRhythm Technologies in the 2nd quarter valued at $85,000. Finally, ETF Managers Group LLC acquired a new position in shares of iRhythm Technologies in the 1st quarter valued at $92,000.

iRhythm Technologies Trading Down 3.5 %

IRTC stock opened at $111.31 on Tuesday. iRhythm Technologies, Inc. has a 12-month low of $85.74 and a 12-month high of $164.69. The stock has a market cap of $3.39 billion, a price-to-earnings ratio of -33.94 and a beta of 1.35. The business’s 50-day moving average is $103.33 and its 200 day moving average is $113.55.

Wall Street Analyst Weigh In

IRTC has been the topic of several analyst reports. Needham & Company LLC cut their price target on iRhythm Technologies from $151.00 to $130.00 and set a “buy” rating on the stock in a research report on Friday. Citigroup increased their price target on iRhythm Technologies from $130.00 to $135.00 in a research report on Friday, May 5th. Oppenheimer increased their price target on iRhythm Technologies from $125.00 to $165.00 in a research report on Friday. StockNews.com initiated coverage on iRhythm Technologies in a research report on Thursday, May 18th. They set a “sell” rating on the stock. Finally, BTIG Research cut their price target on iRhythm Technologies from $165.00 to $140.00 in a research report on Thursday, June 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, iRhythm Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $147.00.

View Our Latest Stock Report on iRhythm Technologies

iRhythm Technologies Profile

(Free Report)

iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Purchased by Mirae Asset Global Investments Co. Ltd.

iRhythm Technologies Trading Down 3.5 %

Wall Street Analyst Weigh In

iRhythm Technologies Profile

See Also

You might be interested in: